A new batch of data for Gilead Sciences’ remdesivir points to efficacy but it’s no ‘silver bullet’

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 50 sec. here
  • 2 min. at publisher
  • 📊 Qulity Score:
  • News: 23%
  • Publisher: 97%

A slice of data from the third clinical trial for Gilead's remdesivir indicates that the experimental therapy is somewhat effective in treating COVID-19 patients -- but is not the silver bullet that had been hoped for. $GIL

United States Headlines News

United States Latest News, United States Headlines

A slice of data from the third clinical trial for Gilead Sciences Inc.’s remdesivir indicates that the experimental therapy is somewhat effective in treating COVID-19 patients but is not the silver bullet that had been hoped for.

The results found that the drug is more effective in patients who received a five-day regimen than those who took the drug for twice as long or those on the standard of care, based on one endpoint: clinical improvement by day 11. The full clinical trial data is expected to be published at a later date.The design of the trial has also raised eyebrows among some analysts and pharmaceutical experts.

Gilead previously shared data from an open-label, Phase 3 clinical study evaluating remdesivir in severely ill patients, as did the National Institute of Allergy and Infectious Diseases from a randomized, placebo-controlled study of the drug. Both data sets were used to inform the Food and Drug Administration’s decision on May 1 to grant emergency use authorization to remdesivir for certain very ill COVID-19 patients.

Today’s numbers:Coronavirus update: Global case tally tops 6 million as weekend protests spark concerns they will lead to an increase in infections

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Gilead slides 4% after coronavirus drug shows limited benefit in moderately ill patients - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web. Fauci hardest hit
Source: BusinessInsider - 🏆 729. / 51 Read more »

Gilead says remdesivir helped moderate COVID-19 patients improveGilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study. Phase 1: reopen retail for curbside pickup Phase 2: gather by the thousands to torch cities and loot businesses Phase 3: reopen churches and gyms at 25% capacity I just can’t get over the name of their company. underhiseye Not in brazil.
Source: Reuters - 🏆 2. / 97 Read more »

Gilead says new data shows remdesivir coronavirus treatment helped moderately sick patientsThe whole world:no,thanks! U.S: Yes I've been in this biz for 25 years. My systems and software oil the gears. Without them you couldn't trade a bond or a stock. Come on Cramer pull your mouth off this rigged market's cock. US Army and USMC will remember in November. Eco. lol - like the ones that would have gotten better without any help from Gilead?
Source: CNBC - 🏆 12. / 72 Read more »

Gilead trades that made millions on COVID-19 drug news raise eyebrowsWell-timed trades in Gilead Sciences Inc's options ahead of good news on the biopharmaceutical company's COVID-19 drug treatment may draw regulatory scrutiny, experts said. Scumbags SOLTARAM OS PRESOS PARA TOCAR O TERROR. ENTENDERAM AGORA ? Somos57MILHOES ¿Remdesivir... singing victory...? Not so soon......vaccines ready at all.......
Source: Reuters - 🏆 2. / 97 Read more »

Gilead says new data shows remdesivir coronavirus treatment helped moderately sick patientsThe whole world:no,thanks! U.S: Yes I've been in this biz for 25 years. My systems and software oil the gears. Without them you couldn't trade a bond or a stock. Come on Cramer pull your mouth off this rigged market's cock. US Army and USMC will remember in November. Eco. lol - like the ones that would have gotten better without any help from Gilead?
Source: CNBC - 🏆 12. / 72 Read more »

Gilead says remdesivir helped moderate COVID-19 patients improveGilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study. Phase 1: reopen retail for curbside pickup Phase 2: gather by the thousands to torch cities and loot businesses Phase 3: reopen churches and gyms at 25% capacity I just can’t get over the name of their company. underhiseye Not in brazil.
Source: Reuters - 🏆 2. / 97 Read more »